A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-Cell epitope for the induction of a highly specific humoral immune response

被引:109
|
作者
Dziadek, S
Hobel, A
Schmitt, E
Kunz, H
机构
[1] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55128 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55101 Mainz, Germany
关键词
antigens; antitumor agents; glycopeptides; synthetic vaccines; T-cell epitope;
D O I
10.1002/anie.200501594
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(Figure Presented) On target: With the fully synthetic vaccine 1 consisting of a tumor-associated sialyl-Tn glycopeptide antigen from the epithelial mucin MUC1 and a T-cell epitope from ovalbumin, a strong, highly specific immune response (IgG) directed against the glycopeptide antigen was induced in a mouse thereby realizing the most important requirement for the development of synthetic vaccines for the initiation of the body's own immune defense against tumors. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:7630 / 7635
页数:6
相关论文
共 50 条
  • [21] Temporal evolution of humoral and T-cell specific immune response to COVID-19 mRNA vaccine in multiple sclerosis
    Ruggieri, S.
    Tortorella, C.
    Aiello, A.
    Farroni, C.
    Haggiag, S.
    Prosperini, L.
    Cuzzi, G.
    Salmi, A.
    Quartuccio, M. E.
    Vanin, V.
    Altera, A. M. G.
    Garbuglia, A. R.
    Lapa, D.
    Meschi, S.
    Maffongelli, G.
    Bartoli, T. Ascoli
    Galgani, S.
    Nicastri, E.
    Gasperini, C.
    Goletti, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 606 - 607
  • [22] Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
    Lechner, Axel
    Schloesser, Hans A.
    Thelen, Martin
    Wennhold, Kerstin
    Rothschild, Sacha, I
    Gilles, Ramona
    Quaas, Alexander
    Siefer, Oliver G.
    Huebbers, Christian U.
    Cukuroglu, Engin
    Goeke, Jonathan
    Hillmer, Axel
    Gathof, Birgit
    Meyer, Moritz F.
    Klussmann, Jens P.
    Shimabukuro-Vornhagen, Alexander
    Theurich, Sebastian
    Beutner, Dirk
    von Bergwelt-Baildon, Michael
    ONCOIMMUNOLOGY, 2019, 8 (03):
  • [23] Tumor Antigen-Specific Monoclonal Antibodies and Induction of T-Cell Immunity
    Trivedi, Sumita
    Jie, Hyun-Bae
    Ferris, Robert L.
    SEMINARS IN ONCOLOGY, 2014, 41 (05) : 678 - 684
  • [24] TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELLS TARGETING PERIPHERAL T CELL LYMPHOMA
    Toner, Keri
    Dave, Hema
    Bollard, Catherine M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S197 - S197
  • [25] GENETIC-CONTROL OF THE CYTOTOXIC T CELL RESPONSE TO SV40 TUMOR-ASSOCIATED SPECIFIC ANTIGEN
    KNOWLES, BB
    KONCAR, M
    PFIZENMAIER, K
    SOLTER, D
    ADEN, DP
    TRINCHIERI, G
    JOURNAL OF IMMUNOLOGY, 1979, 122 (05): : 1798 - 1806
  • [26] Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion
    Wang, Yue
    Hu, Mengying
    Finn, Olivera J.
    Wang, Xiao-Song
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (11) : 1589 - 1602
  • [27] Bispecific T-cell engagers: evaluation of circulating tumor-associated antigen levels and pharmacokinetics
    Gilbert, Amy E.
    Avilion, Ariel
    Doherty, David
    Li, Shyun
    Bailis, Julie
    Rock, Dan
    CANCER RESEARCH, 2016, 76
  • [28] ANTIGEN-SPECIFIC T-CELL FACTORS IN THE REGULATION OF THE IMMUNE-RESPONSE
    THEZE, J
    ANNALES D IMMUNOLOGIE, 1979, C130 (06): : 767 - 780
  • [29] Induction of specific immune response and suppression of fertility by B-cell-epitope-based mimovirus vaccine
    Shen, Zi-gang
    He, Wei
    Zhang, Ji
    He, Hai-yang
    Yang, Xia
    Chen, Zheng-qiong
    Yang, Ping
    Li, Jian
    Liang, Zhi-qing
    Wu, Yu-zhang
    Li, Jin-tao
    REPRODUCTION, 2011, 142 (05) : 659 - 666
  • [30] The immune response of specific T-cell hybridomas on stimulation with synthetic complete antigens
    Holmdahl, M
    Ahlfors, SR
    Holmdahl, R
    Hansson, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (03) : 799 - 799